Browsing by Author Lynch, Jodi

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2016Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE studyBalleine, Rosemary; Gao, Bo-Fu; Gebski, Val; Gurney, Howard; Hui, Rina; Kefford, Richard (Rick); Lee, Clara; Liddle, Christopher; Menzies, Alexander Maxwel; Provan, Pamela; Wilcken, Nicholas; Wong, Ka (Mark); Ali, Sayed Sahanawaz; Balakrishnar, Bavanthi; Coulter, Sally A.; Fox, Peter; Lynch, Jodi; Yeap, Shang Heng; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School (Westmead): Office; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study, Clinical Cancer Research, vol.22, 13, 2016,pp 3164-3171
2012Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancerBeith, Jane; Lawley, Claire; Lynch, Jodi; McCrohon, Jane; Segelov, Eva; Wainwright, Camilla; Central Clinical School: MedicinePilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer, Asia Pacific Journal of Clinical Oncology, vol.8, 1, 2012,pp 95-100
2015Small HER2-positive breast cancer: Should size affect adjuvant treatment?Beith, Jane; Kiely, Belinda Emma; Bastick, Patricia; Descallar, Joseph; Lynch, Jodi; Mok, Kelly; Tognela, Annette; Central Clinical School: Medicine; NH&MRC Clinical Trials CentreSmall HER2-positive breast cancer: Should size affect adjuvant treatment?, Clinical Breast Cancer, vol.15, 4, 2015,pp 277-284